1. Home
  2. FONR vs RCEL Comparison

FONR vs RCEL Comparison

Compare FONR & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FONR
  • RCEL
  • Stock Information
  • Founded
  • FONR 1978
  • RCEL N/A
  • Country
  • FONR United States
  • RCEL United States
  • Employees
  • FONR N/A
  • RCEL N/A
  • Industry
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RCEL Medical/Dental Instruments
  • Sector
  • FONR Health Care
  • RCEL Health Care
  • Exchange
  • FONR Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • FONR 100.6M
  • RCEL 107.8M
  • IPO Year
  • FONR 1987
  • RCEL N/A
  • Fundamental
  • Price
  • FONR $15.23
  • RCEL $3.87
  • Analyst Decision
  • FONR
  • RCEL Buy
  • Analyst Count
  • FONR 0
  • RCEL 5
  • Target Price
  • FONR N/A
  • RCEL $11.80
  • AVG Volume (30 Days)
  • FONR 12.9K
  • RCEL 258.6K
  • Earning Date
  • FONR 09-26-2025
  • RCEL 11-06-2025
  • Dividend Yield
  • FONR N/A
  • RCEL N/A
  • EPS Growth
  • FONR N/A
  • RCEL N/A
  • EPS
  • FONR 1.26
  • RCEL N/A
  • Revenue
  • FONR $104,351,318.00
  • RCEL $74,884,000.00
  • Revenue This Year
  • FONR N/A
  • RCEL $20.40
  • Revenue Next Year
  • FONR N/A
  • RCEL $32.94
  • P/E Ratio
  • FONR $12.08
  • RCEL N/A
  • Revenue Growth
  • FONR 1.43
  • RCEL 38.32
  • 52 Week Low
  • FONR $12.00
  • RCEL $3.60
  • 52 Week High
  • FONR $17.62
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • FONR 42.56
  • RCEL 35.51
  • Support Level
  • FONR $15.21
  • RCEL $3.88
  • Resistance Level
  • FONR $15.60
  • RCEL $4.15
  • Average True Range (ATR)
  • FONR 0.28
  • RCEL 0.25
  • MACD
  • FONR -0.04
  • RCEL -0.08
  • Stochastic Oscillator
  • FONR 31.25
  • RCEL 12.85

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: